Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TK5U
|
|||
| Drug Name |
Aminopyrimidine derivative 6
|
|||
| Synonyms |
PMID26293650-Compound-43
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Myrexis
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H28N6O2
|
|||
| Canonical SMILES |
CC(C)CC(=O)NC1=C(C=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4)C#N
|
|||
| InChI |
1S/C26H28N6O2/c1-18(2)15-25(33)30-23-8-3-19(16-20(23)17-27)24-9-10-28-26(31-24)29-21-4-6-22(7-5-21)32-11-13-34-14-12-32/h3-10,16,18H,11-15H2,1-2H3,(H,30,33)(H,28,29,31)
|
|||
| InChIKey |
MIMBVFVOQLKELD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.